neoplas GmbH
PrivateLast Round
VC Round
Nov 25, 2024
Company Overview
neoplas GmbH is a medical device company that develops and markets cold plasma technology for wound healing in veterinary medicine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neoplas GmbH Comparables
Compare neoplas GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WK-MedTec GmbH | 87% | |
| Coldplasmatech | 83% | |
| CINOGY System | 82% |
neoplas GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 25, 2024 | ||||
| Series B | Apr 24, 2023 | ||||
| Seed | Jun 1, 2022 |
neoplas GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Niterra Ventures | VC Round |
| Pegasus Tech Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2024
$18M round led by Niterra Ventures.
- Apr 24, 2023
Raised Series B with Pegasus Tech Ventures and Niterra Co., Ltd.
neoplas GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about neoplas GmbH's valuation, stock price, and market status.
Is neoplas GmbH a public or private company?
neoplas GmbH is a private company.
What is the current stock price of neoplas GmbH?
neoplas GmbH is a private company with no public stock price. Caplight tracks neoplas GmbH's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is neoplas GmbH worth (valuation)?
Valuation information for neoplas GmbH is not publicly available.
Can I buy neoplas GmbH stock?
neoplas GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was neoplas GmbH's last funding round?
neoplas GmbH's most recent funding round was VC Round on November 25, 2024.
Who are the main investors in neoplas GmbH?
Key investors in neoplas GmbH include Niterra Ventures.
Will neoplas GmbH IPO soon?
No public IPO plans have been announced for neoplas GmbH.
How can I track neoplas GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor neoplas GmbH's secondary market activity and sign up for updates.